Anxiety Disorders Completed Phase 2 Trials for Kava (DB01322)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00451516St. John's Wort And Kava In The Treatment Of Major Depressive Disorder With Comorbid AnxietyTreatment